|
Volumn 404, Issue 10, 2012, Pages 2939-2948
|
Speciation of antimony in injectable drugs used for leishmaniasis treatment (Glucantime®) by HPLC-ICP-MS and DPP
|
Author keywords
Antimony; DPP; Drug; HPLC ICP MS; Leishmaniasis; Speciation
|
Indexed keywords
DPP;
DRUG;
HPLC ICP MS;
LEISHMANIASIS;
SPECIATION;
ANTIMONY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HYDROCHLORIC ACID;
MASS SPECTROMETERS;
REDOX REACTIONS;
INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY;
ANTIMONY;
ANTIPROTOZOAL AGENT;
DRUG;
MEGLUMINE;
MEGLUMINE ANTIMONIATE;
ORGANOMETALLIC COMPOUND;
ARTICLE;
CHEMISTRY;
DRUG EFFECT;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
LEISHMANIA;
MASS SPECTROMETRY;
METHODOLOGY;
SENSITIVITY AND SPECIFICITY;
VALIDATION STUDY;
ANTIMONY;
ANTIPROTOZOAL AGENTS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
HUMANS;
LEISHMANIA;
MASS SPECTROMETRY;
MEGLUMINE;
ORGANOMETALLIC COMPOUNDS;
PHARMACEUTICAL PREPARATIONS;
SENSITIVITY AND SPECIFICITY;
PROTOZOA;
|
EID: 84870906828
PISSN: 16182642
EISSN: 16182650
Source Type: Journal
DOI: 10.1007/s00216-012-6427-3 Document Type: Article |
Times cited : (23)
|
References (24)
|